Kozhamkulov, U.; Iglikova, S.; Rakisheva, A.; Almazan, J.
Multidrug-Resistant Tuberculosis in Central Asia and Predominant Beijing Lineage, Challenges in Diagnosis, Treatment Barriers, and Infection Control Strategies: An Integrative Review. Antibiotics 2025, 14, 673.
https://doi.org/10.3390/antibiotics14070673
AMA Style
Kozhamkulov U, Iglikova S, Rakisheva A, Almazan J.
Multidrug-Resistant Tuberculosis in Central Asia and Predominant Beijing Lineage, Challenges in Diagnosis, Treatment Barriers, and Infection Control Strategies: An Integrative Review. Antibiotics. 2025; 14(7):673.
https://doi.org/10.3390/antibiotics14070673
Chicago/Turabian Style
Kozhamkulov, Ulan, Sholpan Iglikova, Anar Rakisheva, and Joseph Almazan.
2025. "Multidrug-Resistant Tuberculosis in Central Asia and Predominant Beijing Lineage, Challenges in Diagnosis, Treatment Barriers, and Infection Control Strategies: An Integrative Review" Antibiotics 14, no. 7: 673.
https://doi.org/10.3390/antibiotics14070673
APA Style
Kozhamkulov, U., Iglikova, S., Rakisheva, A., & Almazan, J.
(2025). Multidrug-Resistant Tuberculosis in Central Asia and Predominant Beijing Lineage, Challenges in Diagnosis, Treatment Barriers, and Infection Control Strategies: An Integrative Review. Antibiotics, 14(7), 673.
https://doi.org/10.3390/antibiotics14070673